HBW US Roundup: Product Launches, ChromaDex, Mannatech, MusclePharm, USANA Results
Product launches by Power Life Nutrition, PlantFuel Life, Cymbiotik and JSHealth; third-quarter sales up for ChromaDex and Mannatech, slip for MusclePharm and USANA.
You may also be interested in...
Xeltis, a Netherlands-based company producing cardiovascular implants to stimulate natural regeneration of biological tissue, has received funding from the European Union’s rescue fund.
Manufacturers can’t use the US FDA’s voluntary eSTAR product submission program for de novo requests until January – but they can start practicing now on how to use eSTAR for that review pathway.
In an interview with Medtech Insight, Per Vegard Nerserth, CEO of CMR Surgical, discusses how the company adapted to the pandemic, its future plans, and how the competition for market dominance is shaping up.